Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing irinotecan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
Irinotecan hydrochloride (substance) |
Is a |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Camptosar 20mg/ml injection 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Product containing irinotecan in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
Irinotecan liposome (substance) |
Is a |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan liposome (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride trihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Irinotecan (substance) |
Inferred relationship |
Some |
|
Product containing only irinotecan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
Irinotecan only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
FOLFIRI antineoplastic chemotherapy regimen |
Direct substance |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
FOLFIRINOX antineoplastic chemotherapy regimen |
Direct substance |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
1 |
Irinotecan sucrosofate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Irinotecan (substance) |
Inferred relationship |
Some |
|